Rani Therapeutics Holdings, Inc.
Regulated industryPhysical productsDevelopment stageTags from an AI model reading the company description.
Key Metrics
- Previous Close
- $0.56
- 52-Week Range
- $0.50 – $1.91
- Market Cap
- $74.85M
- P/E (TTM)
- —
- EPS (TTM)
- -0.07
- Dividend Yield
- 0.00%
Advanced Metrics
- Price/Book
- 2.20
- PEG Ratio
- —
- Return on Equity
- -233.59%
- Return on Assets
- -69.66%
- Gross Margin
- 100.00%
- Operating Margin
- -530.45%
- Profit Margin
- 0.00%
- Current Ratio
- 5.26
- Debt/Equity
- 0.08
- Total Debt
- $3.15M
- Free Cash Flow
- $-11.65M
- Revenue Growth
- —
- Earnings Growth
- —
- Enterprise Value
- $40.09M
Market Snapshot
About
Rani Therapeutics Holdings, Inc. develops an oral delivery platform using a robotic pill technology that enables biologics to be taken orally instead of through injections, targeting chronic conditions like osteoporosis and inflammatory diseases.